AI assistant
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2014
Nov 21, 2014
29864_dirs_2014-11-21_1fb2b256-13af-46f3-bb6a-a8a05c4d4168.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2014-11-19
Reporting Person: BOGER JOSHUA S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-11-19 | Common Stock | M | 4800 | $10.41 | Acquired | 343695 | Direct |
| 2014-11-19 | Common Stock | M | 1300 | $17.16 | Acquired | 344995 | Direct |
| 2014-11-19 | Common Stock | M | 4400 | $35.64 | Acquired | 349395 | Direct |
| 2014-11-19 | Common Stock | S | 3800 | $113.53 | Disposed | 345595 | Direct |
| 2014-11-19 | Common Stock | S | 2700 | $114.53 | Disposed | 342895 | Direct |
| 2014-11-19 | Common Stock | S | 2300 | $115.42 | Disposed | 340595 | Direct |
| 2014-11-19 | Common Stock | S | 1300 | $116.65 | Disposed | 339295 | Direct |
| 2014-11-19 | Common Stock | S | 400 | $117.75 | Disposed | 338895 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-11-19 | Stock Option (right to buy) | $10.41 | M | 4800 | Disposed | 2015-02-02 | Common Stock (4800) | Direct |
| 2014-11-19 | Stock Option (right to buy) | $17.16 | M | 1300 | Disposed | 2015-07-19 | Common Stock (1300) | Direct |
| 2014-11-19 | Stock Option (right to buy) | $35.64 | M | 4400 | Disposed | 2016-02-01 | Common Stock (4400) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 13286 | Indirect |
| Common Stock | 172589 | Indirect |
Footnotes
F1: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
F2: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3: Open market sales reported on this line occurred at a weighted average price of $113.53 (range $113.08 to $114.07).
F4: Open market sales reported on this line occurred at a weighted average price of $114.53 (range $114.08 to $115.07).
F5: Open market sales reported on this line occurred at a weighted average price of $115.42 (range $115.10 to $116.06).
F6: Open market sales reported on this line occurred at a weighted average price of $116.65 (range $116.30 to $117.11).
F7: Open market sales reported on this line occurred at a weighted average price of $117.75 (range $117.70 to $117.88).
F8: Common stock held in grantor retained annuity trusts.
F9: Fully vested.